Results 11 to 20 of about 3,152,168 (304)
Market structure and market access [PDF]
World Economy, 2007 We examine an issue at the nexus of domestic competition policy and international trade, the interaction between goods trade and market power in domestic trade and distribution sectors. Theory suggests a set of linkages between service-sector competition
Francois, Joseph F., Wooton, Ian
core +10 more sources
The negotiation of improved market access in agriculture is crucial to the success of the Doha Round. The depth of tariff cuts will be the main indication of the level of ambition of the agricultural talks and hence the Round as a whole.
Jales, Mario +3 more
core +3 more sources
Access to Medicines, Access to Markets [PDF]
Frontiers in Sociology, 2020 This article explores some uses by the pharmaceutical industry of language from the "access to medicines" movement in global health, sometimes for goals almost completely opposite to those of the movement. Important in the context of extremely expensive treatments, the industry draws on the idealistic discourse around access to medicines to create a ...
openaire +3 more sources
Pediatric Market Access: A Qualitative Study. [PDF]
Ther Innov Regul SciAbstract Objectives This qualitative study aims to analyze current PM regulation and market access requirements and proposes potential solutions to mitigate current challenges. Methods Twenty-two semi-structured interviews were conducted with experts from pharmaceutical ...
Maas L, Joos A, Hiligsmann M.
europepmc +3 more sources
Choosing formulas for market access negotiations: efficiency and market access considerations [PDF]
, 2005 An important issue in multilateral trade negotiations is the approach taken to reduce tariffs. The authors believe that there are important advantages in formula approaches and survey a range of options between the sharply top-down Swiss formula and proportional cuts in tariffs.
Francois, J., Martin, W., Manole, V.
openaire +5 more sources
Market Access through Bound Tariffs [PDF]
SSRN Electronic Journal, 2009 ABSTRACTWTO negotiations deal predominantly with bound – besides applied – tariff rates. But, how can reductions in tariffs ceilings, i.e. tariff rates that no exporter may ever actually be confronted with, generate market access? The answer to this question relates to the effects of tariff bindings on the risk that exporters face in destination ...
Sala, Davide +2 more
openaire +5 more sources
Bioequivalence centres in Africa: current state and opportunities for growth
Journal of Pharmaceutical Policy and PracticeBioequivalence studies are required for generic medicines to meet the same quality, safety, and efficacy standards as innovator products before receiving marketing authorisation. These studies compare the in vivo performance of a generic medicine to that
Bakani Mark Ncube +3 more
doaj +1 more source
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain
Human Vaccines & ImmunotherapeuticsThe recombinant zoster vaccine (RZV) is included in the Spanish National Immunisation Programme for adults 65 years of age (years), with a potential progressive catch-up program for adults 66–80 years, starting with 80 years.
Andrea García +2 more
doaj +1 more source
Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
Journal of Market Access & Health Policy, 2017 Introduction: Health technology assessment (HTA) in Poland supports reimbursement decisions via the Polish HTA Agency (AOTMiT), whose guidelines were updated in 2016.
Krzysztof Lach +3 more
doaj +1 more source
RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design
Drugs - Real World Outcomes, 2019 Objectives Real-world evidence (RWE) is essential for the development of pharmaceutical and medical technologies and informs treatment-related decisions by regulatory agencies, payers, healthcare providers, and patients.
Andrew D. Xia +4 more
doaj +1 more source